| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ryanodine Receptor Calcium Release Channel | 93 | 2024 | 240 | 17.260 |
Why?
|
| Arrhythmias, Cardiac | 57 | 2024 | 505 | 10.510 |
Why?
|
| Myocytes, Cardiac | 90 | 2024 | 710 | 10.140 |
Why?
|
| Atrial Fibrillation | 56 | 2024 | 747 | 10.070 |
Why?
|
| Calcium | 73 | 2024 | 1593 | 6.990 |
Why?
|
| Sarcoplasmic Reticulum | 56 | 2024 | 197 | 6.720 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 42 | 2024 | 184 | 6.710 |
Why?
|
| Calcium Signaling | 44 | 2024 | 286 | 5.650 |
Why?
|
| Heart Failure | 54 | 2024 | 2381 | 5.110 |
Why?
|
| Tachycardia, Ventricular | 20 | 2023 | 206 | 4.860 |
Why?
|
| Muscle Proteins | 19 | 2024 | 561 | 4.060 |
Why?
|
| Myocardium | 39 | 2024 | 1249 | 3.900 |
Why?
|
| Membrane Proteins | 25 | 2024 | 2974 | 3.890 |
Why?
|
| Cardiomyopathies | 17 | 2024 | 555 | 3.790 |
Why?
|
| Heart Atria | 23 | 2024 | 357 | 3.720 |
Why?
|
| Heart | 24 | 2023 | 1211 | 3.190 |
Why?
|
| Heart Diseases | 11 | 2024 | 736 | 3.110 |
Why?
|
| Anti-Arrhythmia Agents | 15 | 2023 | 235 | 2.600 |
Why?
|
| Long QT Syndrome | 13 | 2023 | 111 | 2.530 |
Why?
|
| Myocardial Contraction | 18 | 2021 | 303 | 2.470 |
Why?
|
| Animals | 192 | 2024 | 62826 | 2.270 |
Why?
|
| Protein Phosphatase 1 | 7 | 2023 | 79 | 2.050 |
Why?
|
| Mice, Transgenic | 43 | 2024 | 4372 | 2.000 |
Why?
|
| Cardiomegaly | 13 | 2024 | 181 | 1.920 |
Why?
|
| Mice | 134 | 2024 | 36058 | 1.920 |
Why?
|
| Muscular Dystrophy, Duchenne | 5 | 2022 | 71 | 1.840 |
Why?
|
| Atrial Remodeling | 3 | 2024 | 13 | 1.840 |
Why?
|
| Tacrolimus Binding Proteins | 15 | 2016 | 83 | 1.820 |
Why?
|
| Disease Models, Animal | 44 | 2024 | 7481 | 1.760 |
Why?
|
| Cardiomyopathy, Dilated | 8 | 2024 | 225 | 1.720 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 17 | 2024 | 259 | 1.690 |
Why?
|
| Heart Rate | 15 | 2020 | 757 | 1.600 |
Why?
|
| Excitation Contraction Coupling | 7 | 2021 | 12 | 1.510 |
Why?
|
| Phosphorylation | 48 | 2024 | 4983 | 1.480 |
Why?
|
| Death, Sudden, Cardiac | 15 | 2020 | 250 | 1.440 |
Why?
|
| Heart Ventricles | 10 | 2024 | 847 | 1.280 |
Why?
|
| Action Potentials | 20 | 2020 | 596 | 1.280 |
Why?
|
| Gene Editing | 2 | 2023 | 231 | 1.250 |
Why?
|
| Electrocardiography | 24 | 2024 | 1192 | 1.210 |
Why?
|
| Calcium-Binding Proteins | 17 | 2020 | 557 | 1.210 |
Why?
|
| Sodium Channels | 8 | 2015 | 115 | 1.200 |
Why?
|
| Mutation | 39 | 2024 | 15954 | 1.110 |
Why?
|
| Mice, Inbred C57BL | 35 | 2020 | 7239 | 1.110 |
Why?
|
| Electric Stimulation | 6 | 2024 | 492 | 1.070 |
Why?
|
| Genetic Therapy | 3 | 2018 | 1739 | 1.030 |
Why?
|
| Ankyrins | 7 | 2020 | 110 | 1.010 |
Why?
|
| Intercellular Junctions | 3 | 2019 | 56 | 1.010 |
Why?
|
| Gene Knockdown Techniques | 7 | 2021 | 1085 | 0.970 |
Why?
|
| Sodium-Calcium Exchanger | 6 | 2023 | 22 | 0.950 |
Why?
|
| Calcium Channels | 7 | 2015 | 214 | 0.940 |
Why?
|
| Humans | 156 | 2024 | 272039 | 0.940 |
Why?
|
| Calpain | 2 | 2024 | 71 | 0.930 |
Why?
|
| Mice, Knockout | 40 | 2021 | 5841 | 0.910 |
Why?
|
| Gene Knock-In Techniques | 8 | 2023 | 184 | 0.900 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2024 | 60 | 0.900 |
Why?
|
| Dependovirus | 3 | 2019 | 143 | 0.900 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 40 | 0.850 |
Why?
|
| Muscular Diseases | 2 | 2022 | 163 | 0.850 |
Why?
|
| Inflammation Mediators | 2 | 2024 | 408 | 0.830 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2024 | 356 | 0.820 |
Why?
|
| Weightlessness | 1 | 2022 | 57 | 0.820 |
Why?
|
| Myosin-Light-Chain Kinase | 3 | 2023 | 74 | 0.790 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2021 | 409 | 0.770 |
Why?
|
| Catheter Ablation | 2 | 2024 | 575 | 0.760 |
Why?
|
| Heart Conduction System | 9 | 2018 | 161 | 0.760 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 10 | 2019 | 42 | 0.740 |
Why?
|
| Genetic Vectors | 4 | 2019 | 1887 | 0.740 |
Why?
|
| Space Flight | 1 | 2022 | 129 | 0.740 |
Why?
|
| Sarcolemma | 4 | 2014 | 31 | 0.680 |
Why?
|
| Physical Conditioning, Animal | 4 | 2020 | 116 | 0.680 |
Why?
|
| Heart Rupture, Post-Infarction | 3 | 2004 | 8 | 0.660 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 15 | 0.660 |
Why?
|
| Cells, Cultured | 24 | 2023 | 5788 | 0.660 |
Why?
|
| Myocardial Reperfusion Injury | 6 | 2019 | 183 | 0.650 |
Why?
|
| Protein Interaction Maps | 2 | 2024 | 151 | 0.650 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2017 | 164 | 0.650 |
Why?
|
| Proteomics | 5 | 2024 | 1437 | 0.640 |
Why?
|
| Tetracaine | 2 | 2016 | 11 | 0.640 |
Why?
|
| Regeneration | 1 | 2021 | 287 | 0.640 |
Why?
|
| Muscle, Skeletal | 6 | 2016 | 1312 | 0.640 |
Why?
|
| Gene Expression Regulation | 14 | 2024 | 4199 | 0.640 |
Why?
|
| Patch-Clamp Techniques | 16 | 2018 | 398 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2021 | 5756 | 0.610 |
Why?
|
| Myocardial Ischemia | 5 | 2019 | 431 | 0.600 |
Why?
|
| Spectrin | 1 | 2018 | 83 | 0.600 |
Why?
|
| Models, Animal | 4 | 2011 | 675 | 0.600 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2015 | 64 | 0.590 |
Why?
|
| Protein Precursors | 1 | 2019 | 250 | 0.580 |
Why?
|
| Mice, Inbred mdx | 6 | 2022 | 44 | 0.580 |
Why?
|
| Fibrosis | 7 | 2024 | 747 | 0.580 |
Why?
|
| Male | 88 | 2024 | 129081 | 0.570 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2022 | 65 | 0.560 |
Why?
|
| Ion Channel Gating | 8 | 2019 | 151 | 0.550 |
Why?
|
| Precision Medicine | 1 | 2024 | 1205 | 0.550 |
Why?
|
| Cyclic AMP Response Element Modulator | 5 | 2024 | 37 | 0.540 |
Why?
|
| Channelopathies | 1 | 2016 | 10 | 0.530 |
Why?
|
| Exercise Test | 2 | 2017 | 313 | 0.530 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2011 | 172 | 0.530 |
Why?
|
| Thiazepines | 5 | 2016 | 11 | 0.520 |
Why?
|
| Cardiac Output, Low | 3 | 2006 | 77 | 0.510 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 813 | 0.510 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2015 | 56 | 0.510 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 42 | 0.510 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 2 | 2017 | 17 | 0.500 |
Why?
|
| Vagus Nerve | 1 | 2015 | 70 | 0.500 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 353 | 0.490 |
Why?
|
| Myotonic Dystrophy | 4 | 2022 | 188 | 0.490 |
Why?
|
| Glutaredoxins | 3 | 2021 | 34 | 0.490 |
Why?
|
| Weightlessness Simulation | 1 | 2014 | 19 | 0.480 |
Why?
|
| Cell Membrane | 3 | 2022 | 900 | 0.480 |
Why?
|
| Phenotype | 15 | 2024 | 6517 | 0.470 |
Why?
|
| Wolff-Parkinson-White Syndrome | 3 | 2024 | 76 | 0.470 |
Why?
|
| Inflammation | 1 | 2024 | 2533 | 0.470 |
Why?
|
| Myocardial Infarction | 6 | 2024 | 1300 | 0.470 |
Why?
|
| Adrenergic beta-Agonists | 5 | 2019 | 140 | 0.460 |
Why?
|
| Mutation, Missense | 6 | 2024 | 1197 | 0.450 |
Why?
|
| Isoproterenol | 9 | 2024 | 135 | 0.440 |
Why?
|
| Signal Transduction | 14 | 2024 | 12228 | 0.440 |
Why?
|
| Physical Endurance | 1 | 2013 | 54 | 0.430 |
Why?
|
| Reactive Oxygen Species | 6 | 2019 | 1011 | 0.430 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 968 | 0.420 |
Why?
|
| Propanolamines | 1 | 2012 | 48 | 0.420 |
Why?
|
| DNA | 4 | 2017 | 3089 | 0.420 |
Why?
|
| Aging | 5 | 2022 | 1578 | 0.420 |
Why?
|
| Sinoatrial Node | 3 | 2023 | 24 | 0.410 |
Why?
|
| Oxidation-Reduction | 7 | 2021 | 718 | 0.410 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 223 | 0.410 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 154 | 0.410 |
Why?
|
| Carbazoles | 1 | 2012 | 91 | 0.410 |
Why?
|
| Catecholamines | 4 | 2017 | 100 | 0.400 |
Why?
|
| Insulin | 2 | 2013 | 1509 | 0.400 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 165 | 0.380 |
Why?
|
| Oxidative Stress | 6 | 2021 | 1156 | 0.380 |
Why?
|
| Microcirculation | 3 | 2002 | 195 | 0.370 |
Why?
|
| Disease Progression | 10 | 2024 | 6909 | 0.370 |
Why?
|
| Hypertension | 5 | 2018 | 1621 | 0.370 |
Why?
|
| Morpholines | 1 | 2012 | 296 | 0.370 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2023 | 115 | 0.370 |
Why?
|
| Receptors, Adrenergic, beta | 6 | 2015 | 102 | 0.370 |
Why?
|
| Phylogeny | 2 | 2014 | 870 | 0.370 |
Why?
|
| NFATC Transcription Factors | 3 | 2022 | 98 | 0.360 |
Why?
|
| Macromolecular Substances | 4 | 2007 | 342 | 0.360 |
Why?
|
| Telemetry | 1 | 2010 | 40 | 0.360 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 10 | 2019 | 39 | 0.360 |
Why?
|
| Circadian Rhythm | 3 | 2020 | 331 | 0.360 |
Why?
|
| Female | 54 | 2024 | 149291 | 0.340 |
Why?
|
| Protein Binding | 9 | 2018 | 3528 | 0.340 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 2334 | 0.330 |
Why?
|
| Echocardiography, Doppler | 1 | 2010 | 186 | 0.330 |
Why?
|
| Sodium | 4 | 2019 | 355 | 0.330 |
Why?
|
| Calmodulin | 4 | 2017 | 264 | 0.330 |
Why?
|
| Carrier Proteins | 2 | 2020 | 2139 | 0.330 |
Why?
|
| Ventricular Remodeling | 5 | 2020 | 188 | 0.330 |
Why?
|
| Death, Sudden | 2 | 2010 | 58 | 0.320 |
Why?
|
| Point Mutation | 4 | 2020 | 793 | 0.310 |
Why?
|
| Sternum | 2 | 2001 | 96 | 0.310 |
Why?
|
| Potassium Channel Blockers | 2 | 2006 | 114 | 0.300 |
Why?
|
| Etiocholanolone | 1 | 2007 | 3 | 0.300 |
Why?
|
| Lidocaine | 2 | 2007 | 79 | 0.300 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2024 | 38 | 0.300 |
Why?
|
| Brugada Syndrome | 1 | 2007 | 20 | 0.300 |
Why?
|
| Fetal Diseases | 1 | 2011 | 449 | 0.300 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2019 | 1527 | 0.300 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2015 | 815 | 0.290 |
Why?
|
| Procollagen-Proline Dioxygenase | 2 | 2019 | 44 | 0.290 |
Why?
|
| Homeostasis | 7 | 2022 | 959 | 0.290 |
Why?
|
| MicroRNAs | 6 | 2019 | 2912 | 0.290 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2019 | 48 | 0.290 |
Why?
|
| Potassium Channels | 2 | 2006 | 196 | 0.290 |
Why?
|
| Protein Phosphatase 2 | 2 | 2019 | 91 | 0.280 |
Why?
|
| Blotting, Western | 7 | 2016 | 3646 | 0.280 |
Why?
|
| Rats | 16 | 2022 | 6640 | 0.280 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 212 | 0.280 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2007 | 138 | 0.280 |
Why?
|
| Models, Cardiovascular | 5 | 2015 | 189 | 0.280 |
Why?
|
| Homeodomain Proteins | 5 | 2020 | 1134 | 0.280 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2019 | 224 | 0.280 |
Why?
|
| Membrane Potentials | 7 | 2013 | 453 | 0.270 |
Why?
|
| Research | 2 | 2015 | 431 | 0.270 |
Why?
|
| Cardiotonic Agents | 1 | 2007 | 160 | 0.260 |
Why?
|
| Cardiology | 2 | 2022 | 552 | 0.260 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2007 | 265 | 0.260 |
Why?
|
| Cell Line | 11 | 2020 | 5433 | 0.260 |
Why?
|
| RNA, Small Interfering | 4 | 2018 | 2219 | 0.260 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 532 | 0.260 |
Why?
|
| Alternative Splicing | 6 | 2021 | 613 | 0.250 |
Why?
|
| Hindlimb | 2 | 2002 | 112 | 0.240 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 116 | 0.240 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 869 | 0.240 |
Why?
|
| Atrial Function, Left | 1 | 2024 | 28 | 0.240 |
Why?
|
| Inflammasomes | 3 | 2023 | 165 | 0.240 |
Why?
|
| Biomarkers | 3 | 2013 | 5098 | 0.240 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 2 | 2023 | 14 | 0.240 |
Why?
|
| Up-Regulation | 7 | 2024 | 2457 | 0.230 |
Why?
|
| RNA, Messenger | 8 | 2022 | 6489 | 0.230 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2021 | 238 | 0.230 |
Why?
|
| Receptors, Adrenergic | 1 | 2024 | 54 | 0.230 |
Why?
|
| Placental Circulation | 1 | 2004 | 24 | 0.230 |
Why?
|
| Connexin 43 | 2 | 2022 | 46 | 0.230 |
Why?
|
| Time Factors | 11 | 2020 | 13135 | 0.230 |
Why?
|
| Intracellular Space | 3 | 2016 | 78 | 0.230 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 227 | 0.230 |
Why?
|
| Ceramides | 1 | 2024 | 91 | 0.220 |
Why?
|
| Tachycardia | 1 | 2024 | 84 | 0.220 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 3 | 2016 | 297 | 0.220 |
Why?
|
| Enzyme Inhibitors | 4 | 2007 | 1966 | 0.220 |
Why?
|
| Polymorphism, Genetic | 2 | 2006 | 1559 | 0.220 |
Why?
|
| Heterotaxy Syndrome | 1 | 2024 | 63 | 0.220 |
Why?
|
| T-Box Domain Proteins | 3 | 2020 | 154 | 0.220 |
Why?
|
| Placenta Diseases | 1 | 2004 | 60 | 0.220 |
Why?
|
| Mice, Mutant Strains | 4 | 2017 | 664 | 0.220 |
Why?
|
| Mitochondria, Heart | 2 | 2024 | 77 | 0.220 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 223 | 0.220 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2024 | 107 | 0.220 |
Why?
|
| Bed Rest | 1 | 2022 | 18 | 0.210 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 665 | 0.210 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 131 | 0.210 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 2287 | 0.210 |
Why?
|
| Stress, Psychological | 1 | 2010 | 1039 | 0.210 |
Why?
|
| Echocardiography | 7 | 2016 | 1238 | 0.210 |
Why?
|
| Pedigree | 2 | 2024 | 2042 | 0.210 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2020 | 70 | 0.210 |
Why?
|
| Exercise Tolerance | 1 | 2003 | 109 | 0.210 |
Why?
|
| Rett Syndrome | 3 | 2016 | 284 | 0.210 |
Why?
|
| DNA-Binding Proteins | 7 | 2023 | 5067 | 0.210 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2022 | 10 | 0.210 |
Why?
|
| Astronauts | 1 | 2022 | 58 | 0.200 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2022 | 25 | 0.200 |
Why?
|
| Transcription Factors | 6 | 2020 | 5506 | 0.200 |
Why?
|
| Hemangioma | 1 | 2004 | 161 | 0.200 |
Why?
|
| Cell Physiological Phenomena | 1 | 2022 | 25 | 0.200 |
Why?
|
| Ion Channels | 2 | 2014 | 241 | 0.200 |
Why?
|
| NADPH Oxidase 2 | 2 | 2020 | 44 | 0.200 |
Why?
|
| Desmoplakins | 2 | 2020 | 17 | 0.200 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2004 | 235 | 0.200 |
Why?
|
| Folic Acid | 1 | 2024 | 371 | 0.190 |
Why?
|
| Physical Exertion | 3 | 2015 | 114 | 0.190 |
Why?
|
| Publications | 1 | 2001 | 54 | 0.190 |
Why?
|
| Microtubules | 3 | 2022 | 330 | 0.190 |
Why?
|
| Myotonin-Protein Kinase | 1 | 2021 | 49 | 0.190 |
Why?
|
| Molecular Structure | 3 | 2007 | 531 | 0.190 |
Why?
|
| Fibronectins | 1 | 2021 | 210 | 0.190 |
Why?
|
| Enzyme Activation | 4 | 2017 | 1831 | 0.190 |
Why?
|
| Pregnancy, Animal | 2 | 2018 | 105 | 0.190 |
Why?
|
| Mitochondrial Proteins | 2 | 2014 | 385 | 0.190 |
Why?
|
| Rats, Wistar | 3 | 2017 | 601 | 0.190 |
Why?
|
| Amino Acid Substitution | 5 | 2020 | 661 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 3 | 2020 | 544 | 0.180 |
Why?
|
| Down-Regulation | 4 | 2023 | 2106 | 0.180 |
Why?
|
| Heredity | 1 | 2020 | 26 | 0.180 |
Why?
|
| Cell Nucleus | 2 | 2020 | 1740 | 0.180 |
Why?
|
| Kainic Acid | 1 | 2020 | 41 | 0.180 |
Why?
|
| Running | 1 | 2020 | 43 | 0.180 |
Why?
|
| Paracrine Communication | 1 | 2020 | 130 | 0.170 |
Why?
|
| Electroencephalography | 3 | 2020 | 996 | 0.170 |
Why?
|
| Structure-Activity Relationship | 4 | 2007 | 1005 | 0.170 |
Why?
|
| Calcitonin | 1 | 2020 | 181 | 0.170 |
Why?
|
| Fetus | 1 | 2004 | 674 | 0.170 |
Why?
|
| Protein Subunits | 3 | 2011 | 282 | 0.170 |
Why?
|
| Myocardial Reperfusion | 1 | 2000 | 104 | 0.170 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2000 | 135 | 0.170 |
Why?
|
| Ventricular Function | 1 | 2000 | 100 | 0.170 |
Why?
|
| Fibrinogen | 1 | 2020 | 214 | 0.170 |
Why?
|
| Sodium Channel Blockers | 2 | 2015 | 37 | 0.170 |
Why?
|
| Gene Deletion | 2 | 2014 | 1487 | 0.170 |
Why?
|
| Amino Acid Sequence | 5 | 2020 | 4635 | 0.160 |
Why?
|
| Risk Factors | 7 | 2020 | 18024 | 0.160 |
Why?
|
| Ranolazine | 1 | 2018 | 2 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 4 | 2020 | 3262 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2020 | 1093 | 0.160 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 895 | 0.160 |
Why?
|
| Biological Clocks | 2 | 2016 | 39 | 0.160 |
Why?
|
| RNA Interference | 3 | 2018 | 1397 | 0.160 |
Why?
|
| Immunoblotting | 3 | 2015 | 909 | 0.160 |
Why?
|
| Diabetes Complications | 1 | 2021 | 315 | 0.160 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2000 | 229 | 0.160 |
Why?
|
| Protein Conformation | 3 | 2020 | 1278 | 0.160 |
Why?
|
| Calcineurin | 2 | 2010 | 131 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1997 | 339 | 0.160 |
Why?
|
| Organogenesis | 1 | 2019 | 110 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 1133 | 0.150 |
Why?
|
| Status Epilepticus | 1 | 2020 | 161 | 0.150 |
Why?
|
| Protein Isoforms | 4 | 2021 | 860 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2021 | 851 | 0.150 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 1782 | 0.150 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 307 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2001 | 260 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2024 | 1720 | 0.150 |
Why?
|
| Keratosis | 1 | 2017 | 37 | 0.150 |
Why?
|
| Cell Proliferation | 6 | 2023 | 7308 | 0.150 |
Why?
|
| Cardiovascular Agents | 1 | 2018 | 113 | 0.150 |
Why?
|
| Computational Biology | 3 | 2016 | 1282 | 0.150 |
Why?
|
| Phosphoserine | 2 | 2010 | 109 | 0.150 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 88 | 0.150 |
Why?
|
| Fibrinolytic Agents | 1 | 2000 | 302 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2016 | 1212 | 0.140 |
Why?
|
| Flecainide | 2 | 2015 | 29 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 181 | 0.140 |
Why?
|
| DNA Mutational Analysis | 4 | 2017 | 2365 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1433 | 0.140 |
Why?
|
| Cholinergic Neurons | 1 | 2016 | 25 | 0.140 |
Why?
|
| Homozygote | 1 | 2019 | 771 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2016 | 1730 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2019 | 832 | 0.140 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2016 | 17 | 0.140 |
Why?
|
| Muscle, Striated | 2 | 2014 | 13 | 0.140 |
Why?
|
| Neoplasms | 1 | 2023 | 15914 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 3651 | 0.140 |
Why?
|
| Cell Size | 3 | 2013 | 145 | 0.140 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 86 | 0.130 |
Why?
|
| RNA | 2 | 2018 | 1072 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2020 | 809 | 0.130 |
Why?
|
| Thermogenesis | 1 | 2016 | 51 | 0.130 |
Why?
|
| Muscle Cells | 2 | 2012 | 33 | 0.130 |
Why?
|
| Cold Temperature | 1 | 2016 | 127 | 0.130 |
Why?
|
| Wound Infection | 1 | 1996 | 66 | 0.130 |
Why?
|
| Students, Medical | 1 | 2001 | 421 | 0.130 |
Why?
|
| Pericarditis | 1 | 1996 | 61 | 0.130 |
Why?
|
| Nanostructures | 1 | 2016 | 102 | 0.130 |
Why?
|
| Vascular Stiffness | 1 | 2016 | 80 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2016 | 270 | 0.130 |
Why?
|
| Random Allocation | 2 | 2018 | 745 | 0.130 |
Why?
|
| Genetic Loci | 1 | 2018 | 497 | 0.130 |
Why?
|
| Protein Interaction Mapping | 1 | 2016 | 169 | 0.130 |
Why?
|
| Adipose Tissue, Brown | 1 | 2016 | 116 | 0.130 |
Why?
|
| HEK293 Cells | 2 | 2017 | 1470 | 0.130 |
Why?
|
| Sick Sinus Syndrome | 1 | 2015 | 12 | 0.130 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 7830 | 0.130 |
Why?
|
| Muscle Contraction | 3 | 2005 | 230 | 0.130 |
Why?
|
| Brain Stem | 1 | 2016 | 185 | 0.130 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 154 | 0.130 |
Why?
|
| Atrial Function | 1 | 2015 | 15 | 0.130 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2015 | 25 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2021 | 1004 | 0.130 |
Why?
|
| Hematoma | 1 | 1996 | 159 | 0.130 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2015 | 35 | 0.130 |
Why?
|
| Mitochondria | 3 | 2024 | 1313 | 0.130 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 6783 | 0.130 |
Why?
|
| Treatment Outcome | 7 | 2024 | 33913 | 0.120 |
Why?
|
| Lactation | 1 | 2016 | 244 | 0.120 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 175 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 767 | 0.120 |
Why?
|
| HeLa Cells | 1 | 2018 | 1718 | 0.120 |
Why?
|
| Microfilament Proteins | 2 | 2014 | 498 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 1096 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2015 | 322 | 0.120 |
Why?
|
| Hindlimb Suspension | 1 | 2014 | 16 | 0.120 |
Why?
|
| Immunoprecipitation | 3 | 2023 | 593 | 0.120 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 420 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 2014 | 49 | 0.120 |
Why?
|
| Middle Aged | 19 | 2024 | 90457 | 0.120 |
Why?
|
| Cadmium | 1 | 2014 | 47 | 0.120 |
Why?
|
| Angiotensin II | 2 | 2013 | 204 | 0.120 |
Why?
|
| Electric Countershock | 1 | 2014 | 70 | 0.120 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 34 | 0.120 |
Why?
|
| Binding Sites | 3 | 2016 | 2298 | 0.120 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 82 | 0.120 |
Why?
|
| Calcium-Transporting ATPases | 2 | 2004 | 70 | 0.120 |
Why?
|
| Digitoxin | 1 | 2013 | 11 | 0.120 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 3417 | 0.110 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 195 | 0.110 |
Why?
|
| Electrophysiology | 4 | 2015 | 364 | 0.110 |
Why?
|
| Blood Pressure | 4 | 2016 | 1598 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 1996 | 312 | 0.110 |
Why?
|
| Rabbits | 3 | 2016 | 1077 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 349 | 0.110 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2013 | 16 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 180 | 0.110 |
Why?
|
| Sequence Alignment | 3 | 2020 | 883 | 0.110 |
Why?
|
| Chromatin | 1 | 2019 | 1050 | 0.110 |
Why?
|
| Needs Assessment | 1 | 2014 | 237 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 235 | 0.110 |
Why?
|
| Phosphoproteins | 1 | 2019 | 1230 | 0.110 |
Why?
|
| Models, Biological | 3 | 2009 | 3223 | 0.110 |
Why?
|
| Benzylamines | 3 | 2012 | 101 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 149 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 407 | 0.110 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 635 | 0.100 |
Why?
|
| Pacemaker, Artificial | 1 | 2015 | 206 | 0.100 |
Why?
|
| Stress, Physiological | 2 | 2015 | 494 | 0.100 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 3071 | 0.100 |
Why?
|
| Stroke Volume | 2 | 2012 | 552 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2020 | 1670 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 641 | 0.100 |
Why?
|
| Serine | 3 | 2012 | 394 | 0.100 |
Why?
|
| Exons | 2 | 2023 | 1388 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1996 | 338 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2016 | 5105 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2020 | 1756 | 0.100 |
Why?
|
| Ventricular Fibrillation | 1 | 2012 | 63 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 1483 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2399 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 1146 | 0.100 |
Why?
|
| Superoxides | 1 | 2012 | 222 | 0.100 |
Why?
|
| Aged | 13 | 2020 | 73500 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1164 | 0.100 |
Why?
|
| Leukocytes | 3 | 2002 | 426 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2012 | 137 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2015 | 472 | 0.090 |
Why?
|
| Transcriptome | 1 | 2020 | 1950 | 0.090 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2009 | 116 | 0.090 |
Why?
|
| Adenoviridae | 1 | 2016 | 1514 | 0.090 |
Why?
|
| Caffeine | 4 | 2015 | 96 | 0.090 |
Why?
|
| Transfection | 4 | 2011 | 3166 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 1996 | 682 | 0.090 |
Why?
|
| RNA-Binding Proteins | 3 | 2014 | 1026 | 0.090 |
Why?
|
| Pulmonary Artery | 1 | 2014 | 521 | 0.090 |
Why?
|
| Adult | 12 | 2024 | 81993 | 0.090 |
Why?
|
| Apoptosis | 3 | 2023 | 7842 | 0.090 |
Why?
|
| Digoxin | 1 | 2010 | 53 | 0.090 |
Why?
|
| Thrombolytic Therapy | 2 | 2004 | 258 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 882 | 0.090 |
Why?
|
| Arteries | 2 | 2024 | 294 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 5194 | 0.090 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2010 | 47 | 0.090 |
Why?
|
| NADPH Oxidases | 3 | 2016 | 148 | 0.090 |
Why?
|
| Ligation | 1 | 2010 | 208 | 0.090 |
Why?
|
| Sudden Infant Death | 1 | 2009 | 34 | 0.090 |
Why?
|
| Dogs | 4 | 2018 | 1169 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2016 | 1892 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 470 | 0.080 |
Why?
|
| Escape Reaction | 1 | 2009 | 15 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 1606 | 0.080 |
Why?
|
| Colchicine | 2 | 2022 | 72 | 0.080 |
Why?
|
| Antioxidants | 1 | 2012 | 522 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 160 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2010 | 324 | 0.080 |
Why?
|
| Adenosine Diphosphate | 2 | 2017 | 101 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2009 | 146 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 341 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2012 | 792 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2008 | 106 | 0.080 |
Why?
|
| Computer Simulation | 3 | 2013 | 1573 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 126 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2015 | 2256 | 0.080 |
Why?
|
| Isolated Heart Preparation | 2 | 2019 | 4 | 0.080 |
Why?
|
| Prognosis | 2 | 2020 | 22543 | 0.080 |
Why?
|
| Substrate Specificity | 2 | 2007 | 582 | 0.080 |
Why?
|
| Sulfonamides | 4 | 2018 | 1930 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2011 | 834 | 0.080 |
Why?
|
| Rats, Inbred Lew | 3 | 2002 | 119 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2020 | 6882 | 0.070 |
Why?
|
| Calcium Channel Agonists | 1 | 2007 | 15 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2009 | 419 | 0.070 |
Why?
|
| Patents as Topic | 1 | 2007 | 27 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2012 | 4964 | 0.070 |
Why?
|
| Caveolins | 1 | 2007 | 79 | 0.070 |
Why?
|
| CELF1 Protein | 3 | 2014 | 46 | 0.070 |
Why?
|
| Case-Control Studies | 5 | 2020 | 6233 | 0.070 |
Why?
|
| Rats, Inbred WKY | 1 | 2007 | 112 | 0.070 |
Why?
|
| Heat Stroke | 1 | 2007 | 4 | 0.070 |
Why?
|
| Rats, Inbred SHR | 1 | 2007 | 113 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2014 | 801 | 0.070 |
Why?
|
| Malignant Hyperthermia | 1 | 2007 | 24 | 0.070 |
Why?
|
| Glucose | 1 | 2013 | 1246 | 0.070 |
Why?
|
| Syncope | 1 | 2006 | 61 | 0.070 |
Why?
|
| Acute Disease | 2 | 2012 | 2510 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1599 | 0.070 |
Why?
|
| Ultrasonography | 3 | 2015 | 1941 | 0.070 |
Why?
|
| ERG1 Potassium Channel | 1 | 2006 | 3 | 0.070 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 2006 | 5 | 0.070 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2006 | 21 | 0.070 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2006 | 7 | 0.070 |
Why?
|
| Atropine | 2 | 2016 | 44 | 0.070 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2006 | 18 | 0.070 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 1 | 2006 | 14 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2011 | 2289 | 0.070 |
Why?
|
| Child | 7 | 2024 | 30577 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2012 | 1668 | 0.070 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2024 | 693 | 0.060 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2006 | 70 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2008 | 915 | 0.060 |
Why?
|
| Comorbidity | 1 | 2012 | 2428 | 0.060 |
Why?
|
| Cytoskeleton | 2 | 2016 | 304 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 1905 | 0.060 |
Why?
|
| Transgenes | 2 | 2019 | 589 | 0.060 |
Why?
|
| Animals, Newborn | 3 | 2015 | 1396 | 0.060 |
Why?
|
| Kidney | 2 | 2012 | 2263 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 5187 | 0.060 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2024 | 25 | 0.060 |
Why?
|
| Uncoupling Protein 3 | 2 | 2014 | 9 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 6208 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2024 | 1850 | 0.060 |
Why?
|
| Fetal Monitoring | 1 | 2004 | 57 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2005 | 2337 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2002 | 542 | 0.050 |
Why?
|
| Microarray Analysis | 2 | 2015 | 398 | 0.050 |
Why?
|
| Ventricular Function, Left | 2 | 2020 | 570 | 0.050 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2002 | 19 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2008 | 774 | 0.050 |
Why?
|
| Neurons | 1 | 2014 | 2463 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2024 | 2129 | 0.050 |
Why?
|
| Dystrophin | 1 | 2022 | 48 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2019 | 545 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2023 | 114 | 0.050 |
Why?
|
| Adrenergic Agents | 1 | 2022 | 21 | 0.050 |
Why?
|
| Pregnancy | 3 | 2018 | 8112 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2023 | 8627 | 0.050 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 250 | 0.050 |
Why?
|
| Proteolysis | 1 | 2024 | 379 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2004 | 417 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 298 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 58 | 0.050 |
Why?
|
| E-Selectin | 1 | 2002 | 109 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 48 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 97 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2023 | 339 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 593 | 0.050 |
Why?
|
| Acylation | 1 | 2021 | 22 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 534 | 0.050 |
Why?
|
| Receptors, Calcitonin | 1 | 2020 | 28 | 0.050 |
Why?
|
| Obesity | 3 | 2021 | 2944 | 0.050 |
Why?
|
| Genotype | 2 | 2014 | 4268 | 0.050 |
Why?
|
| Microscopy, Video | 1 | 2000 | 32 | 0.050 |
Why?
|
| Arterioles | 1 | 2000 | 34 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2024 | 911 | 0.040 |
Why?
|
| Kinetics | 2 | 2000 | 2242 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2021 | 142 | 0.040 |
Why?
|
| Hypoxia | 1 | 2023 | 477 | 0.040 |
Why?
|
| Proteome | 1 | 2024 | 573 | 0.040 |
Why?
|
| Video Recording | 1 | 2002 | 283 | 0.040 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 104 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2020 | 124 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2020 | 190 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 267 | 0.040 |
Why?
|
| Genes, Dominant | 2 | 2015 | 360 | 0.040 |
Why?
|
| Ischemic Preconditioning | 1 | 2019 | 21 | 0.040 |
Why?
|
| Middle East | 1 | 2019 | 44 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1997 | 727 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 254 | 0.040 |
Why?
|
| Vasodilation | 1 | 2000 | 217 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2023 | 17062 | 0.040 |
Why?
|
| Protein Transport | 2 | 2012 | 739 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 1106 | 0.040 |
Why?
|
| Indenes | 1 | 2018 | 12 | 0.040 |
Why?
|
| Perfusion | 2 | 2015 | 285 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 234 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2022 | 534 | 0.040 |
Why?
|
| Diploidy | 1 | 2019 | 116 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2016 | 1569 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 164 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2021 | 448 | 0.040 |
Why?
|
| Furans | 1 | 2018 | 103 | 0.040 |
Why?
|
| Family | 1 | 2022 | 779 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2004 | 920 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 889 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2019 | 252 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 146 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 134 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 126 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 1295 | 0.040 |
Why?
|
| Sheep | 1 | 2017 | 273 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2015 | 1742 | 0.040 |
Why?
|
| Neutrophils | 1 | 2002 | 876 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 52 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 188 | 0.040 |
Why?
|
| Epinephrine | 2 | 2009 | 249 | 0.040 |
Why?
|
| Chick Embryo | 1 | 1997 | 219 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2000 | 567 | 0.040 |
Why?
|
| Parasympathetic Nervous System | 1 | 2016 | 26 | 0.040 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2016 | 45 | 0.040 |
Why?
|
| Antigens | 1 | 2017 | 283 | 0.040 |
Why?
|
| Tiopronin | 1 | 2016 | 2 | 0.030 |
Why?
|
| Pleurisy | 1 | 1996 | 12 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1997 | 210 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2020 | 9484 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 278 | 0.030 |
Why?
|
| Dantrolene | 1 | 2016 | 9 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2017 | 249 | 0.030 |
Why?
|
| Electrophoresis | 1 | 2016 | 75 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2001 | 408 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 504 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 84 | 0.030 |
Why?
|
| Chickens | 1 | 1997 | 791 | 0.030 |
Why?
|
| Skin | 1 | 2002 | 1284 | 0.030 |
Why?
|
| Radiography | 1 | 2001 | 1994 | 0.030 |
Why?
|
| Milk Proteins | 1 | 2016 | 134 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2016 | 116 | 0.030 |
Why?
|
| Hemodynamics | 3 | 2009 | 967 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 162 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2019 | 706 | 0.030 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2016 | 4195 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2015 | 60 | 0.030 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2015 | 10 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 1095 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2000 | 642 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2016 | 329 | 0.030 |
Why?
|
| Muscarine | 1 | 2015 | 17 | 0.030 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 49 | 0.030 |
Why?
|
| Hyperventilation | 1 | 2015 | 21 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2016 | 254 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 196 | 0.030 |
Why?
|
| Abscess | 1 | 1996 | 192 | 0.030 |
Why?
|
| NAD | 1 | 2015 | 88 | 0.030 |
Why?
|
| Phenytoin | 1 | 2015 | 84 | 0.030 |
Why?
|
| Potassium | 1 | 2016 | 348 | 0.030 |
Why?
|
| Defibrillators, Implantable | 1 | 2017 | 227 | 0.030 |
Why?
|
| Propranolol | 1 | 2015 | 160 | 0.030 |
Why?
|
| Nocodazole | 1 | 2014 | 28 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2023 | 1545 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2016 | 594 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 417 | 0.030 |
Why?
|
| Syndrome | 1 | 2017 | 1407 | 0.030 |
Why?
|
| Adolescent | 4 | 2020 | 32759 | 0.030 |
Why?
|
| Glutathione | 1 | 2016 | 376 | 0.030 |
Why?
|
| Cell Communication | 1 | 2017 | 518 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2017 | 39828 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2013 | 4 | 0.030 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 65 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2013 | 24 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 910 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 203 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2014 | 113 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 334 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 339 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 128 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2017 | 906 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 476 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 347 | 0.030 |
Why?
|
| Atrial Appendage | 1 | 2013 | 57 | 0.030 |
Why?
|
| Base Sequence | 2 | 2010 | 5502 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2013 | 82 | 0.030 |
Why?
|
| Gene Expression | 2 | 2017 | 3690 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 399 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2019 | 2150 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 194 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2021 | 1699 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 703 | 0.030 |
Why?
|
| Myofibrils | 1 | 2012 | 31 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 269 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 674 | 0.030 |
Why?
|
| Serum Response Factor | 1 | 2012 | 41 | 0.030 |
Why?
|
| Blood Urea Nitrogen | 1 | 2012 | 100 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 464 | 0.030 |
Why?
|
| Lipid Bilayers | 1 | 2012 | 57 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 44 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 1501 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 725 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2012 | 135 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 2598 | 0.030 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2012 | 31 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 512 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 689 | 0.020 |
Why?
|
| Infant | 3 | 2015 | 13984 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 4899 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 995 | 0.020 |
Why?
|
| Microscopy | 1 | 2012 | 193 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 661 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 221 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 1649 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 7963 | 0.020 |
Why?
|
| Bacteremia | 1 | 1996 | 722 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 680 | 0.020 |
Why?
|
| Calcium Channels, L-Type | 1 | 2011 | 76 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2016 | 1322 | 0.020 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2009 | 7 | 0.020 |
Why?
|
| Theophylline | 1 | 2009 | 36 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2009 | 14 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 5941 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2010 | 42 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 280 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 758 | 0.020 |
Why?
|
| United States | 2 | 2021 | 16033 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2012 | 329 | 0.020 |
Why?
|
| Goats | 1 | 2009 | 70 | 0.020 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2009 | 17 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 636 | 0.020 |
Why?
|
| Citrate (si)-Synthase | 1 | 2009 | 20 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 599 | 0.020 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2008 | 85 | 0.020 |
Why?
|
| Jagged-1 Protein | 1 | 2008 | 103 | 0.020 |
Why?
|
| Facies | 1 | 2008 | 154 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 755 | 0.020 |
Why?
|
| Alagille Syndrome | 1 | 2008 | 48 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 727 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 22173 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 1074 | 0.020 |
Why?
|
| Myopathy, Central Core | 1 | 2007 | 6 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 1513 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 81 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2006 | 41 | 0.020 |
Why?
|
| Static Electricity | 1 | 2006 | 62 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2005 | 19 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 2268 | 0.020 |
Why?
|
| Catalysis | 1 | 2006 | 246 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2006 | 136 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2006 | 167 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2008 | 829 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 673 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 196 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 1335 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 2201 | 0.020 |
Why?
|
| Finland | 1 | 2004 | 66 | 0.010 |
Why?
|
| Ion Transport | 1 | 2004 | 76 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 5519 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1997 | 4496 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 3417 | 0.010 |
Why?
|
| Magnesium | 1 | 2004 | 172 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 286 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2003 | 19 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 1528 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2003 | 99 | 0.010 |
Why?
|
| Diastole | 1 | 2003 | 188 | 0.010 |
Why?
|
| Butadienes | 1 | 2002 | 36 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 2496 | 0.010 |
Why?
|
| Venules | 1 | 2002 | 30 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2012 | 31071 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 5112 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 278 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2006 | 919 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 2001 | 73 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 298 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 384 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2001 | 738 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2001 | 499 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 682 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 9318 | 0.010 |
Why?
|
| Edema | 1 | 2001 | 265 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2002 | 1041 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2000 | 601 | 0.010 |
Why?
|
| Nitriles | 1 | 2002 | 945 | 0.010 |
Why?
|
| Desmin | 1 | 1997 | 64 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2003 | 901 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1997 | 782 | 0.010 |
Why?
|
| Swine | 1 | 1997 | 1610 | 0.010 |
Why?
|
| Prostate | 1 | 1997 | 1138 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 5804 | 0.010 |
Why?
|